Spain-based pan-European REIT Healthcare Activos has presented a “strategic roadmap” for expanding Europe’s elderly care capacity to MEPs at the European Parliament, given that the continent’s 80+ population will roughly double by 2050.
naturalX Health Ventures, a venture capital fund backed by Schwabe Group, a plant-based pharmaceutical group, has announced a €100 million fund to accelerate the consumer health revolution in Europe.
Cera, a UK-based health tech company providing home healthcare, has secured more than $150 million funding, led by funds affiliated with merchant bank BDT & MSD Partners and investment manager Schroders Capital.
The UK government’s Department of Health and Social Care (DHSC) has unveiled plans for an upgraded NHS App to enable more patients in England to choose providers, book appointments in more settings, and receive test results in one place.
Switzerland has voted to overhaul how its healthcare system is financed. Inpatient and outpatient care will both be financed in the same way from 2028, which should enable private outpatient clinics to compete on a more level playing field with public hospitals, particularly in specialisms which are increasingly done on an outpatient basis, such as ophthalmology.
George Murgatroyd, General Manager & Vice President at the Digital Technologies division of Medtronic, the world’s largest medtech company, shared his thoughts with HBI on how far we really need to go to effectively take the NHS from “analogue” to “digital”. Plus, what the role of Medtronic and medtech is in this reform, as demand for tech solutions in healthcare rises.
Finland’s government has announced a program to introduce a more standard primary care model in which everyone is registered with a local GP, to improve its struggling primary care system. Details of exactly how this will be implemented have yet to be decided, but it looks likely to involve more outsourcing to for-profit providers. But politics could make bold changes to the system difficult.
Germany’s cabinet coalition government has collapsed. This means a major reform launched by (soon to be former) Health Minister Karl Lauterbach which in its original form proposed effectively banning “locust” investors from buying outpatient facilities, but had subsequently been heavily watered down, will now not be passed at all. The desire to increase restrictions on private investment may live on in future governments, however.
Germany’s federal states are attempting to amend the Hospital Care Improvement Act (Krankenhausversorgungsverbesserungsgesetz, KHVVG), which was approved by Germany’s Bundestag in October but still has to be voted on by the upper house. The federal health ministry is threatening to withhold finance for the states if they block the reform.
Health Minister Karl Lauterbach’s long-awaited reform to Germany’s hospital sector is to become law after being passed by the Bundestag (the country’s legislature). The reform is likely to lead to many of the country’s smaller unspecialised inpatient facilities being either shut or converted into outpatient facilities.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.